rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Richard Chen

President and CMO

Company insider

Files Form 4 as: President and CMO, Personalis.

In numbers

Trades disclosed
126
Buys
0
Sells
57
Bought
$0
Sold
$10.7M
Companies
1
Companies where not an officer
0
First trade
7 Mar 2012
Last trade
18 Sep 2026
Last filed
22 Sep 2026

Companies traded

Where they are an officer
PSNL PersonalisOfficer · Diagnostics & Labs · last 18 Sep 20260 buys · 57 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Sep 2026filed 22 Sep 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$65K3,998 at $16.22filing
18 Sep 2026filed 22 Sep 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$65K3,998 at $16.22filing
15 Jul 2026filed 15 Jul 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Code M$244K100,000 at $2.44filing
15 Jul 2026filed 15 Jul 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$1.5M100,000 at $15.15filing
15 Jul 2026filed 15 Jul 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—100,000 at $0.00filing
15 Jul 2026filed 15 Jul 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—100,000 at $0.00filing
15 Jul 2026filed 15 Jul 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Code M$244K100,000 at $2.44filing
15 Jul 2026filed 15 Jul 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$1.5M100,000 at $15.15filing
15 Mar 2026filed 17 Mar 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Code A—46,875 at $0.00filing
15 Mar 2026filed 17 Mar 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—281,250 at $0.00filing
15 Mar 2026filed 17 Mar 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—281,250 at $0.00filing
15 Mar 2026filed 17 Mar 2026PSNL PersonalisDiagnostics & LabsSEC FORM 4 Code A—46,875 at $0.00filing
23 Feb 2026filed 25 Feb 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—15,000 at $0.00filing
23 Feb 2026filed 25 Feb 2026PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—15,000 at $0.00filing
28 Jul 2025filed 30 Jul 2025PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$2,970452 at $6.57filing
16 May 2025filed 20 May 2025PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$4,505910 at $4.95filing
15 Mar 2025filed 18 Mar 2025PSNL Personalisoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—250,000 at $0.00filing
28 Jan 2025filed 30 Jan 2025PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$3,005519 at $5.79filing
16 Dec 2024filed 18 Dec 2024PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$18K4,834 at $3.82filing
18 Nov 2024filed 20 Nov 2024PSNL PersonalisDiagnostics & LabsSEC FORM 4 Sold$3,491921 at $3.79filing

News

Personalis, Inc.: Personalis NeXT Personal Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026PSNL · finanznachrichten.de · 21 Oct 2026

0 headlines in the last 90 days name Richard Chen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care57

Buys in green, sells in red, by the company’s sector.

Related people

Stephen Michael MooreSVP and Chief Legal Officer · SVP and Chief Legal Officer at Personalis, filing Form 4 there in the last year
Aaron TachibanaCFO and COO · CFO and COO at Personalis, filing Form 4 there in the last year
Christopher M. HallChief Executive Officer · Chief Executive Officer at Personalis, filing Form 4 there in the last year
Karin EasthamDirector · Director at Personalis, filing Form 4 there in the last year
A. Blaine BowmanDirector · Director at Personalis, filing Form 4 there in the last year